Liquid compositions for the oral administration of lorazepam
WO0249642A2
Use of 5-hydroxy and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofuranacetic acids and their esters as agents useful for healing skin lesions and stimulants of angiogenesis
EP1001773A1
Oral solid pharmaceutical compositions containing nicorandil for a modulated release and the process for their preparation
CN1240790A
Salts of D-fructose-1,6-bis(dihydrogen phosphate) with organic amine and pharmaceutical compositions containing them
EP0848953A1
5-Hydroxy- and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofurane-acetic acids and their esters for treating and preventing diabetic complications
EP0865442A1
IMIDAZO[1,2-a]QUINOXALIN-4-AMINES ACTIVE AS ADENOSINE ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF
EP0606853A1
New process for obtaining octahydro trisodium salt of fructose 1,6-diphosphate (FdPNa3H*8H20) in a crystalline form
GR1001558B
Pharmaceutical preparation based on buflomedil hydrochloride, in the form of controlled release tablets, and relevant preparation process.
EP0552712A1
8-(1-Aminocycloalkyl)-1,3-dialkylxanthine derivatives as antagonists adenosine receptors
CA2037683A1
Process for the synthesis of 5-acyloxy and 5-alkoxy-2,3-dihydro-4,6,7-trimethyl-2-(rs)- benzofuranacetic acids
US5114966A
2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)-substituted, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties
US5039330A
Use of fructose-1,6-diphosphate in botany as germination and plant growth promoter
US4916220A
Palmitoyl-fructose-1,6-diphosphate, its therapeutic use and relevant preparation methods
US4999350A
(RS)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) acetic acids and 2-(2,3-dihydro-5-acyloxy-4,6,7-trimethylbenzofuranyl) acetic acids and esters thereof, useful as mucoregulator and anti-ischemic drugs
EP0337003A2
Use of fructose-1,6-diphosphate in the treatment of acute alcoholic intoxication and chronic ethylism, and related pharmaceutical compositions
ES2008753A6
Release-controlled tablet type medicinal preparation based on buflomedil hydrochloride and manufacture
ES2004774A6
Process for the continuous production of fructose-1,6-di-phosphate by employ of immobilized yeast
JPS62272977A
Method for holding phosphorization activity of yeast used inproduction of fructose-1, 6-diphosphate
DE3701162A1
NEW THERAPEUTIC USE OF FRUCTOSE-1,6-DIPHOSPHATE FOR PROTECTION AGAINST TOXICITY, CAUSED BY LONG-TERM ADMINISTRATION OF ANTITUMOR MEDICINES OF THE ANTHRACYCLIN SERIES
IT8522099D0
Crystalline tri:sodium salts of fructose phosphate
